[1] CHRISTENSON S A,SMITH B M,BAFADHEL M,et al.Chronic obstructive pulmonary disease[J].Lancet,2022,399(10342):2227-2242.
[2] RITCHIE A I,WEDZICHA J A.Definition,causes,pathogenesis,and consequences of chronic obstructive pulmonary disease exacerbations[J].Clin Chest Med,2020,41(3):421-438.
[3] RUAN H,ZHANG H,WANG J,et al.Readmission rate for acute exacerbation of chronic obstructive pulmonary disease:A systematic review and meta-analysis[J].Respir Med,2023,206:107090.
[4] HALPIN D M G,CRINER G J,PAPI A,et al.Global initiative for the diagnosis,management,and prevention of chronic obstructive lung disease.The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease [J].Am J Respir Crit Care Med,2021,203(1):24-36.
[5] HUANG S,JIANG J.Etiological characteristics and risk factors of chronic obstructive pulmonary disease combined with infection [J].Tohoku J Exp Med,2025,264(4):179-184.
[6] 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J].国际呼吸杂志,2017,37(14):1041-1057.
[7] 彭丽阁,周宸,周海霞,等.慢性阻塞性肺疾病急性加重住院患者院内死亡危险因素分析[J].中华医学杂志,2021,101(48):3932-3937.
[8] 刘文,王西华.社区获得性肺炎病原学检测研究进展[J].现代医学,2022,50(11):1490-1494.
[9] 徐敏,杨露.老年脑梗死鼻饲患者发生吸入性肺炎的危险因素分析及预测模型构建[J].东南大学学报(医学版),2024,43(5):704-711.
[10] 贾晶晶,唐西怀,殷娟.慢性阻塞性肺疾病患者肺部感染的病原学及危险因素研究[J].临床肺科杂志,2019,24(3):477-480.
[11] HOGEA S P,TUDORACHE E,FILDAN A P,et al.Risk factors of chronic obstructive pulmonary disease exacerbations[J].Clin Respir J,2020,14(3):183-197.
[12] HERDER C,RODEN M,VENTECLEF N.Diabetes and pulmonary infection:how hyperglycaemia shapes the immune system[J].Signal Transduct Target Ther,2024,9(1):67.
[13] 莫贤伦,谢月萍,林媛媛,等.中国糖尿病患者发生肺部感染危险因素的Meta分析[J].实用心脑肺血管病杂志,2024,32(10):94-99.
[14] 徐余娟,李寅.老年脑梗死后吞咽困难患者发生吸入性肺炎的影响因素分析及预测模型构建[J].现代医学,2025,53(2):279-286.
[15] YAMASHITA A,KITAMURA M,TATEISHI Y,et al.Correlation between a bedridden status and the long-term outcome in hemodialysis patients after intracerebral hemorrhaging [J].Intern Med,2022,61(8):1133-1138.
[16] 刘霞,郭丝雨,张紫薇.长期卧床老年病人并发肺炎的危险因素及Nomogram预测模型构建[J].护理研究,2023,37(16):2909-2914.
[17] 李潇一,马艺展,井鹏程.慢性阻塞性肺疾病急性加重期患者发生肺部感染的影响因素分析[J].中国实用医刊,2024,51(11):38-41.
[18] 贺晓娇,黎思浓,段程.慢性阻塞性肺疾病稳定期患者肺部感染发生的影响因素[J].中国医药导报,2021,18(10):96-99,112.
[19] 王永红,周中丽,黄中秀,等.耐碳青霉烯类鲍曼不动杆菌医院感染暴发调查及危险因素分析[J].中国感染与化疗杂志,2020,20(3):259-265.
[20] MARCHI E,HINKS T S C,RICHARDSON M,et al.The effects of inhaled corticosteroids on healthy airways[J].Allergy,2024,79(7):1831-1843.
[21] PATEL B,PRIEFER R.Impact of chronic obstructive pulmonary disease,lung infection,and/or inhaled corticosteroids use on potential risk of lung cancer[J].Life Sci,2022,294:120374.
[22] 张璐,于涛.慢性阻塞性肺疾病合并社区获得性肺炎风险列线图的建立及验证[J].东南大学学报(医学版),2024,43(6):882-889.
[23] 张丽,范忠杰,周凡.慢性阻塞性肺疾病急性加重期肺部感染患者的病原菌分布、耐药性及危险因素分析[J].中国病原生物学杂志,2019,14(12):1456-1459. |